The Unequal Geographic Burden of Lung Cancer
The lung cancer death rate—the number of lung cancer deaths per 100,000 U.S. men and women—has been decreasing slowly...
Tag: Lung cancer
The lung cancer death rate—the number of lung cancer deaths per 100,000 U.S. men and women—has been decreasing slowly...
The past month has seen the U.S. Food and Drug Administration (FDA) expand the use of four anticancer therapeutics,...
Monday ushered in a ray of hope and promise for the lung cancer community at the AACR Annual Meeting...
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the immunotherapeutic durvalumab (Imfinzi) to include...
A diverse group of about 220 physicians, patient advocates, and scientists in basic, translational, and clinical lung cancer research...
Cigarette smoking is the leading cause of death from lung cancer in the United States. That’s why November, Lung...
Last week, a flurry of U.S. Food and Drug Administration (FDA) oncology approvals concluded with the approval of the...
Earlier this week, the U.S. Food and Drug Association (FDA) announced it had approved the immunotherapeutic atezolizumab (Tecentriq) for...
Cancer Today Senior Editor Marci A. Landsmann shares her experience reporting on a young lung cancer survivor, Emily Bennett...
Dr. Patricia LoRusso works to find innovative therapeutics to reduce the toll of cancer on patients and their families.